GLSINasdaqPharmaceutical PreparationsFiscal year ends December 31
Greenwich LifeSciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$15.21+0.66 (+4.54%)
Close on Oct 19, 2026
- Market cap
- $222.39M
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
-$19.45MFY2025